Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is O-DESMETHYL VENLAFAXINE SUCCINATE, with a corresponding US DMF Number 22372.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2014, and payment made on November 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II